BusinessWorld
April 22, 2021 | 4:33 pm
Vials with Pfizer-BioNTech, AstraZeneca, and Moderna coronavirus disease vaccine labels are seen in front of a US flag in this illustration picture taken March 19, 2021. REUTERS/DADO RUVIC
THE BIDEN administration is weighing an appeal from progressive Democrats to accelerate global access to COVID-19 vaccines by supporting a waiver of intellectual-property protections, a move opposed by big drug makers.
Lawmakers led by senators Bernie Sanders and Elizabeth Warren last week called on President Joseph R. Biden to back a proposal before the World Trade Organization (WTO) that seeks a broad waiver from obligations on the protection of intellectual property rights, including patents, copyrights and trade secrets.
U S weighs global vaccine intellectual property waiver opposed by drugmakers japantimes.co.jp - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from japantimes.co.jp Daily Mail and Mail on Sunday newspapers.
Email
America reaches milestone with COVID-19 vaccine widely available to those who want it, but hesitancy still casts a shadow
USA TODAY s panel of experts celebrate the success of the U.S. COVID-19 vaccine program but worry that although most Americans can get a shot, too many won t.
Karen Weintraub and Elizabeth Weise, USA TODAY
Published
5:48 pm UTC Apr. 19, 2021
As of Monday, COVID-19 vaccines are available to every American over 16 who wants a shot, but a panel of experts convened by USA TODAY remains deeply concerned about the people who say vaccines aren t needed.
Anxiety about getting a shot is normal, expected and can be resolved with education and role models, several panelists said.
COVID vaccine appointments open to most Americans, but hesitancy looms usatoday.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from usatoday.com Daily Mail and Mail on Sunday newspapers.